• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A Virus-like Particle that Elicits Cross-reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin

tetano

Editor, Senior Moderator
J Virol. 2012 Aug 15. [Epub ahead of print]
A Virus-like Particle that Elicits Cross-reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin.
Schneemann A, Speir JA, Tan GS, Khayat R, Ekiert DC, Matsuoka Y, Wilson IA.
Source

Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037.
Abstract

The discovery of broadly neutralizing antibodies that recognize highly conserved epitopes in the membrane-proximal region of influenza virus hemagglutinin (HA) has revitalized efforts to develop a universal influenza virus vaccine. This effort will likely require novel immunogens that contain these epitopes but lack the variable and immunodominant epitopes located in the globular head of HA. As a first step toward developing such an immunogen, we investigated whether the 20-residue A-helix of the HA2 chain that forms the major component of the epitope of broadly neutralizing antibodies CR6261, F10 and others is sufficient by itself to elicit antibodies with similarly broad antiviral activity. Here we report multivalent display of the A-helix on icosahedral virus-like particles (VLPs) derived from the capsid of Flock House virus (FHV). Mice immunized with VLPs displaying 180 copies/particle of the A-helix produced antibodies that recognized trimeric HA and the elicited antibodies had binding characteristics similar to those of CR6261 and F10: they recognized multiple HA subtypes from group 1, but not group 2. However, the anti A-helix antibodies did not neutralize influenza virus. These results indicate that further engineering of the transplanted peptide is required and that display of additional regions of the epitope may be necessary to achieve protection.

PMID:
22896619
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22896619
 
Back
Top Bottom